Lunes 09:00 - 14:00 15:00 - 18:30 Martes 09:00 - 14:00 15:00 - 18:30 Miércoles 09:00 - 14:00 15:00 - 18:30 Jueves 09:00 - 14:00 15:00 - 18:30 Viernes 09:00 - 15:00

Vircell

Casa
España
Granada
Vircell

Biotechnology company dedicated to providing diagnostic solutions for human infectious diseases.

Biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases

Compañía de biotecnología especializada en el desarrollo y producción de reactivos listos para el diagnóstico de enfermedades infecciosas

05/11/2025

🚀 We’re heading to MEDICA 2025!
📍 Hall 3, Booth 3A30 – Düsseldorf, Germany
📅 November 17–20

Discover the latest immunological and molecular solutions designed to empower modern laboratories.
We hope to see you there and connect in person! 💚

31/10/2025

This week, our SAT team hosted a new training program called "Train the Trainer"at Vircell’s headquarters in Granada 🇪🇸, a three-day training designed to strengthen knowledge and collaboration with our distributors around the world.

🔧 During these sessions, participants deepened their understanding of VirClia® Lotus and shared experiences to enhance technical expertise and support capabilities.

👏 A big thank you to all attendees for joining us, and to every Vircell department involved for making this program possible. Collaboration and knowledge sharing remain key to continuous improvement.

27/10/2025

Every laboratory has its own rhythm, that’s why VirClia® H. pylori Monotest is designed to adapt, offering a fully automated, on-demand solution for the detection of H. pylori antibodies.

💡 Compatible with Cary Blair medium, allowing direct use of routine samples without additional processing.

⚙️ Compared to other automated systems, this kit provides the same reliability with simpler handling and faster turnaround.

22/10/2025

🧪 More than 25 million VirClia® tests around the world.

A number that goes beyond a figure, it represents the trust of laboratories, clinicians, and professionals who rely on VirClia® every day to deliver accurate and reliable results.

We’re proud to be part of the daily work of thousands of labs that make early detection and patient care possible.
To all who make it happen, thank you.

20/10/2025

🧬 Start your workflow with confidence.
The new VIRPLEX Extraction Kits bring automation, precision, and reliability to your molecular routine.

💠 Nanomagnetic bead technology
💠 Minimal hands-on time
💠 Reproducible and traceable results
💠 CE-IVDR certified

Automated extraction, ready-to-use reagents, and DNA/RNA ready for amplification, all part of the Vircell Molecular Complete Solution.

17/10/2025

This year we joined the Medical Mycology Training Network (MMTN) in Manado, a great opportunity to exchange knowledge and connect with professionals from across Asia working to advance medical mycology.

🎤 Our colleague Alejandro Martín delivered a session on invasive fungal infections, addressing key clinical challenges and presenting the VirClia® Galactomannan Monotest (CLIA) as part of the discussion.

🙏 Thanks to all organizers and participants for an engaging and collaborative meeting. We value every chance to keep building bridges between science, technology, and the people behind it.

14/10/2025

Joaquín Ortiz represented Vircell at the Mexican Congress of Clinical Pathology, one of the main IVD events in Mexico, together with our partner Kabla.

He delivered two scientific talks:

🧫 “40 Years of Helicobacter pylori: Advances in Diagnosis and New Challenges for the Future”, focused on progress in detection methods and future perspectives.

🦠 “Nontuberculous Mycobacteria: An Unnoticed Threat with a Growing Impact on Public Health”, addressing their increasing relevance in clinical microbiology.

Events like this are a great opportunity to exchange knowledge and strengthen collaborations in the field of infectious diseases

02/10/2025

🧳 In 2024, Europe confirmed its first imported Oropouche cases were confirmed in Italy, Spain and Germany, mostly in travelers returning from Cuba.

⚠️ With >10,000 cases reported in Latin America in 2024, early detection in Europe is key. ✅Diagnosis relies on RT-PCR, making lab preparedness essential.

At Vircell, we support laboratories with the Oropouche-Mayaro Virus Real-time PCR Kit (RTPCR032-LP-R), designed for sensitive and multiplex detection of emerging arboviruses:

🧬 Multiplex detection (3 targets in 1 well)
🧬 24-test kit (3 strips of 8 wells)
🧬 Lyophilized format

30/09/2025

Our colleague Daniel Ruiz, Application Specialist at Vircell, highlights the key advantages of Lotus:
✔️ The widest infectious diseases panel in CLIA
✔️ Continuous loading and random access
✔️ Multi-parameter testing for running any number of VirClia® assays simultaneously

📍 Join us at MEDICA 2025 (17–20 November, Düsseldorf) to discover the Lotus in action and explore the rest of our solutions.

24/09/2025

El TIMM 2025 en Bilbao ha sido una experiencia inolvidable. 🌍✨
Una gran oportunidad para volver a conectar con profesionales apasionados por la micología médica y compartir perspectivas sobre los retos actuales.

Presentamos nuestro ensayo VirClia® Aspergillus Galactomannan y su papel en la detección de infecciones fúngicas.
Seguimos firmes en nuestro compromiso de impulsar el progreso científico y apoyar a los laboratorios clínicos en su trabajo diario. 🧪
-------------------------------------------------------------------------------------------------

What an incredible few days at TIMM 2025 in Bilbao! 🌍✨
A great opportunity to reconnect with professionals passionate about medical mycology and to exchange perspectives on today’s challenges.

We showcased our VirClia® Aspergillus Galactomannan assay and its role in the detection of fungal infections.
We remain committed to driving scientific progress and supporting clinical laboratories in their daily work. 🧪

22/09/2025

🦟 Dengue is the fastest spreading mosquito-borne viral disease worldwide, with nearly 400 million infections annually. In Europe, incidence is rising, especially in France, where autochthonous cases have sharply increased in recent years.

🔬 An independent evaluation of the VirClia® Dengue IgM assay was recently conducted at the University Hospital of Lille, with support from the French Reference Center for Arboviruses.

✅ The study, published in the Journal of Tropical Medicine, highlights the value of fully automated monotest immunoassays like VirClia® in providing fast, reliable IgM results.

📄 Read the technical note here:https://www.vircell.com/sites/default/files/2025-09/Dengue%20IgM%20VirClia%20french%20evaluation%20%20Sept%202025_0.pdf

--------------------------------------------------------------------------------------------------

🦟 El dengue es la enfermedad vírica transmitida por mosquitos de mayor expansión en el mundo, con cerca de 400 millones de infecciones anuales. En Europa su incidencia está aumentando, especialmente en Francia, donde los casos autóctonos han crecido de forma notable en los últimos años.

🔬 Una evaluación independiente del ensayo VirClia® Dengue IgM se ha realizado recientemente en el Hospital Universitario de Lille, con el apoyo del Centro Nacional de Referencia de Arbovirus en Francia.

✅ El estudio, publicado en el Journal of Tropical Medicine, pone de relieve el valor de los inmunoensayos monotest totalmente automatizados como VirClia®, que ofrecen resultados rápidos y fiables en IgM.

📄 Accede a la nota técnica aquí:https://www.vircell.com/sites/default/files/2025-09/Dengue%20IgM%20VirClia%20french%20evaluation%20%20Sept%202025_0.pdf

18/09/2025

🇬🇧
🚨 New launch! Meet our new Clostridium difficile GDH Ag VirClia® Monotest, a fully automated solution for detecting one of the leading causes of healthcare-associated diarrhea.

🦠 Clostridium difficile is a global threat, often emerging after antibiotic use. With VirClia® you get:

✅ Fast and easy pre-analytical treatment (no centrifugation needed)
✅ Results in just 1 hour
✅ On-demand testing: 1 monotest = 1 reported test
✅ Individual quality control built into every test
✅ High sensitivity and specificity with objective results

👉 Flexible, automated, and designed for today’s lab needs.
🔍 Learn more on our website!
https://www.vircell.com/en

--------------------------------------------------------------------------------------------------------------------------------------------------

🇪🇸
🚨 ¡Nuevo lanzamiento! Presentamos el nuevo Clostridium difficile GDH Ag VirClia® Monotest, una solución totalmente automatizada para la detección de una de las principales causas de diarrea asociada a la atención sanitaria.

🦠 Clostridium difficile es una amenaza global que prolifera especialmente tras el uso de antibióticos. Con VirClia® obtienes:

✅ Tratamiento preanalítico rápido y sencillo (sin centrifugación)
✅ Resultados en solo 1 hora
✅ Test bajo demanda: 1 monotest = 1 resultado
✅ Control de calidad individual en cada test
✅ Máxima sensibilidad y especificidad con resultados objetivos

👉 Flexible, automatizado y pensado para las necesidades del laboratorio actual.
🔍 Más información en nuestra web.
https://www.vircell.com/

Dirección

Calle Avicena, 8
Granada
18006

Horario de Apertura

Lunes	09:00 - 14:00
	15:00 - 18:30
Martes	09:00 - 14:00
	15:00 - 18:30
Miércoles	09:00 - 14:00
	15:00 - 18:30
Jueves	09:00 - 14:00
	15:00 - 18:30
Viernes	09:00 - 15:00

Página web

http://www.vircell.com/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Vircell publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.